News Releases

Month Year

Month Year

Feb 16, 2005

Insmed Provides Response to UK Patent Lawsuit
Jan 7, 2005

University of Rochester Awarded $6.5 Million to Study Efficacy OF rhIGF-I/rhIGFBP-3, SomatoKine, in the Treatment of Myotonic Dystrophy
Jan 3, 2005

Insmed Submits New Drug Application -NDA- to Seek Regulatory Approval of SomatoKine for the Treatment of Growth Hormone Insensitivity Syndrome
Dec 31, 2004

Insmed Completes New Drug Application -NDA- for SomatoKine for the Treatment of Growth Hormone Insensitivity Syndrome; Conference Call Scheduled for 11:00 am January 5, 2005
Dec 30, 2004

Insmed Incorporated Released the Following Statement in Response to Recent Actions by Tercica, Inc.
Dec 21, 2004

Insmed Incorporated Released the Following Statement in Response to a Press Release Made Yesterday by Tercica, Inc.
Nov 9, 2004

Insmed Announces Expansion of Patent Portfolio in the Treatment of Diabetes; New European Patent Granted for SomatoKine
Nov 8, 2004

Insmed Raises Approximately $8.7 Million in Direct Placement of Common Stock
Nov 8, 2004

Insmed Incorporated Reports Financial Results for Third Quarter and First Nine-Months of 2004
Oct 26, 2004

Insmed to Present at Rodman and Renshaw Healthcare Conference October 28, 2004; Presentation to Be Webcast Live

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

View the latest Insmed Investor Presentation